In patients with benign breast tumors, the IL-6 level was not significantly correlated with the aforementioned indicators in routine blood tests (P > 0.05), but it was positively correlated with IL-17, TNF-α, and IFN-γ levels (P < 0.01), as shown in Tables 6, 7, respectively. The gene discussed is IL17A; the disease is breast benign neoplasm.